While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

TOKYO -- Swiss pharmaceutical company Novartis plans to start mass production of radiopharmaceuticals, a type of next-generation cancer treatment, in Japan in 2026, Nikkei has learned. The company ...

ZURICH, March 6 (Reuters) - Novartis (NOVN.S), opens new tab is not panicking about higher tariffs on pharmaceutical imports that U.S. President Donald Trump could impose, the drug maker's ...

Roche announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored phase III OUtMATCH study, which provide further evidence supporting the role of Xolair ...

Few large companies appear to have the appetite to make big acquisitions in healthcare this year. Startups desperate to sell may find better luck with other digital health companies flush with cash.

UC Inclusive Credit Private Limited has sanctioned Term Loan of Rs. 8,00,00,000/- (Rupees Eight Crores Only) to Akme Fintrade (India) Limited. Shares of Akme Fintrade India Limited was last ...

Medical professionals don’t pursue careers in healthcare out of a love of data entry, but it’s an inescapable daily reality for most, taking time away from focused care and consultations with ...